Feb 20 (Reuters) - Sarissa Capital Management LP kicked off a proxy battle with Ariad Pharmaceuticals Inc on Friday, demanding the retirement of Harvey Berger, the drugmaker's chief executive and principal founder.

from Reuters: Company News http://ift.tt/1EdaAIA
via IFTTT
from Reuters: Company News http://ift.tt/1EdaAIA
via IFTTT
No hay comentarios:
Publicar un comentario